Q32 Bio (QTTB) Current Deferred Revenue (2017 - 2023)
Q32 Bio's Current Deferred Revenue was $354,000 in Q1 2023, down 89.0% from $3.21 million a year earlier and down 69.4% from the prior quarter.
Powered by 
Analysis
Q32 Bio (QTTB) Current Deferred Revenue (2017 - 2023) Analysis & Trends
At the end of FY2022, Current Deferred Revenue at Q32 Bio came in at $1.16 million, down 64.0% from FY2021.
- Current Deferred Revenue shows a five-year compound annual growth rate of -19.1% (FY2017 to FY2022).
- In earlier years, Current Deferred Revenue was $3.21 million in FY2021 (-43.0%), $5.63 million in FY2020 (+596.2%), $809,000 in FY2019 (+5.1%) and $770,000 in FY2018 (-77.0%).
- The Q1 2023 figure marks the lowest quarterly Current Deferred Revenue in data going back to Q4 2017.
- Compared with a year earlier, Current Deferred Revenue has declined for six straight quarters, with growth averaging 15.3% over the last eight quarters.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q4 2020 (growth of 596.2%); the worst was Q1 2023 (a decline of 89.0%).
- Per Business Quant data, QTTB's Current Deferred Revenue in the three quarters before Q1 2023 was $1.16 million (Q4 2022), $1.96 million (Q3 2022) and $2.76 million (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Q32 Bio | 196.30 Mn | -77.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 354,000.00 |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 1.96 Mn |
| Jun 30, 2022 | 2.76 Mn |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 3.21 Mn |
| Sep 30, 2021 | 3.21 Mn |
| Jun 30, 2021 | 4.01 Mn |
| Mar 31, 2021 | 5.18 Mn |
| Dec 31, 2020 | 5.63 Mn |
| Sep 30, 2020 | 2.94 Mn |
| Jun 30, 2020 | 774,000.00 |
| Mar 31, 2020 | 774,000.00 |
| Dec 31, 2019 | 809,000.00 |
| Sep 30, 2019 | 774,000.00 |
| Jun 30, 2019 | 690,000.00 |
| Mar 31, 2019 | 905,000.00 |
| Dec 31, 2018 | 770,000.00 |
| Sep 30, 2018 | 3.61 Mn |
| Jun 30, 2018 | 3.50 Mn |
API Access
Q32 Bio Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=QTTB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "QTTB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=QTTB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();